1. Home
  2. GL vs NBIX Comparison

GL vs NBIX Comparison

Compare GL & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globe Life Inc.

GL

Globe Life Inc.

N/A

Current Price

$165.28

Market Cap

14.3B

Sector

Finance

ML Signal

N/A

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$141.13

Market Cap

15.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GL
NBIX
Founded
1900
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.3B
15.5B
IPO Year
1998
1996

Fundamental Metrics

Financial Performance
Metric
GL
NBIX
Price
$165.28
$141.13
Analyst Decision
Buy
Strong Buy
Analyst Count
11
28
Target Price
$193.91
★ $208.40
AVG Volume (30 Days)
298.5K
★ 978.0K
Earning Date
10-21-2026
10-27-2026
Dividend Yield
★ 0.80%
N/A
EPS Growth
17.84
★ 41.95
EPS
★ 7.04
3.30
Revenue
★ $5,994,318,000.00
$161,626,000.00
Revenue This Year
$6.77
$36.49
Revenue Next Year
$6.52
$16.51
P/E Ratio
★ $23.58
$41.88
Revenue Growth
3.74
★ 977.51
52 Week Low
$127.85
$122.14
52 Week High
$191.55
$186.12

Technical Indicators

Market Signals
Indicator
GL
NBIX
Relative Strength Index (RSI) 32.16 38.83
Support Level $147.40 $125.18
Resistance Level $176.61 $142.82
Average True Range (ATR) 3.07 3.63
MACD -0.45 -0.24
Stochastic Oscillator 5.00 27.51

Price Performance

Historical Comparison
GL
NBIX

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: